These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2384668)

  • 21. Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide.
    Sredni B; Albeck M; Tichler T; Shani A; Shapira J; Bruderman I; Catane R; Kaufman B; Kalechman Y
    J Clin Oncol; 1995 Sep; 13(9):2342-53. PubMed ID: 7666093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.
    Kalechman Y; Gafter U; Weinstein T; Chagnac A; Freidkin I; Tobar A; Albeck M; Sredni B
    J Biol Chem; 2004 Jun; 279(23):24724-32. PubMed ID: 15001575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin.
    Sredni B; Kalechman Y; Albeck M; Gross O; Aurbach D; Sharon P; Sehgal SN; Gurwith MJ; Michlin H
    Immunology; 1990 Aug; 70(4):473-7. PubMed ID: 2118479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular inflammation stimulated by the immunomodulator AS101 [ammonium trichloro(dioxyethelene-O-O') tellurate].
    Dastgheib K; Hikita N; Sredni B; Albeck M; Sredni D; Nussenblatt RB; Chan CC
    Curr Eye Res; 1994 Aug; 13(8):603-10. PubMed ID: 7956313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of B16 melanoma metastasis by the immunomodulator AS101.
    Xu R; Kalechman Y; Albeck M; Kung H; Sredni B
    Int J Oncol; 1996 Aug; 9(2):319-25. PubMed ID: 21541518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c mice.
    Rosenblatt-Bin H; Kalechman Y; Vonsover A; Xu RH; Da JP; Shalit F; Huberman M; Klein A; Strassmann G; Albeck M; Sredni B
    Cell Immunol; 1998 Feb; 184(1):12-25. PubMed ID: 9626331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biological activity and immunotherapeutic properties of AS-101, a synthetic organotellurium compound.
    Sredni B; Caspi RR; Lustig S; Klein A; Kalechman Y; Danziger Y; Ben Ya'akov M; Tamari T; Shalit F; Albeck M
    Nat Immun Cell Growth Regul; 1988; 7(3):163-8. PubMed ID: 3262821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The organotellurium compound ammonium trichloro(dioxoethylene-o,o')tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice.
    Okun E; Dikshtein Y; Carmely A; Saida H; Frei G; Sela BA; Varshavsky L; Ofir A; Levy E; Albeck M; Sredni B
    FEBS J; 2007 Jun; 274(12):3159-70. PubMed ID: 17521335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels.
    Kalechman Y; Gafter U; Da JP; Albeck M; Alarcon-Segovia D; Sredni B
    J Immunol; 1997 Sep; 159(6):2658-67. PubMed ID: 9300685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cytoprotective effect of the immunomodulator AS101 against hydrochloride induced gastric lesions.
    Xu RH; Kalechman Y; Albeck M; Sredni B
    Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):4-20. PubMed ID: 7735728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation by ammonium trichloro(dioxoethylene-0,0') tellurate (AS101) of Fas/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101.
    Kalechman Y; Strassmann G; Albeck M; Sredni B
    J Immunol; 1998 Oct; 161(7):3536-42. PubMed ID: 9759874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression.
    Sredni B; Gal R; Cohen IJ; Dazard JE; Givol D; Gafter U; Motro B; Eliyahu S; Albeck M; Lander HM; Kalechman Y
    FASEB J; 2004 Feb; 18(2):400-2. PubMed ID: 14656992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel involvement of the immunomodulator AS101 in IL-10 signaling, via the tyrosine kinase Fer.
    Hayun R; Shpungin S; Malovani H; Albeck M; Okun E; Nir U; Sredni B
    Ann N Y Acad Sci; 2007 Jan; 1095():240-50. PubMed ID: 17404037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic effects of AS101 in the treatment of cancer patients.
    Shani A; Tichler T; Catane R; Gurwith M; Rozenszajn LA; Gezin A; Levi E; Schlesinger M; Kalechman Y; Michlin H
    Nat Immun Cell Growth Regul; 1990; 9(3):182-90. PubMed ID: 2370878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibabesial effect of the immunomodulator AS101 in mice: role of increased production of nitric oxide.
    Rosenblatt-Bin H; Klein A; Sredni B
    Parasite Immunol; 1996 Jun; 18(6):297-306. PubMed ID: 9229382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway.
    Hayun M; Naor Y; Weil M; Albeck M; Peled A; Don J; Haran-Ghera N; Sredni B
    Biochem Pharmacol; 2006 Nov; 72(11):1423-31. PubMed ID: 16889755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
    Patchen ML; Fischer R; MacVittie TJ
    Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of the bacterial extract Broncho-Vaxom enhances radiation recovery and myelopoietic regeneration.
    Fedorocko P; Macková NO; Brezáni P; Kopka M
    Immunopharmacology; 1994; 28(2):163-70. PubMed ID: 8002290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the novel tellurium compound AS101 on autoimmune diseases.
    Halpert G; Sredni B
    Autoimmun Rev; 2014 Dec; 13(12):1230-5. PubMed ID: 25153485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
    Inoue H; Koezuka Y; Nishi N; Osawa M; Motoki K; Kobayashi E; Kabaya K; Obuchi M; Fukushima H; Mori KJ
    Exp Hematol; 1997 Aug; 25(9):935-44. PubMed ID: 9257806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.